MDGL vs PH · rev $180.1M vs P/E 28, rev $19.85B
Madrigal Pharmaceuticals Inc (MDGL) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
MDGL currently screens at market cap $11.56B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the MDGL and PH stock pages for the full models.
Not investment advice.